Study to Assess the Ability of the Cytuity™ Device to Collect Cell Samples from the Fallopian Tube to Evaluate the Presence or Absence of Malignancy

Overview

About this study

The purpose of this study is to assess the ability of the Cytuity™ device to collect cell samples from the fallopian tube that can be evaluated for the presence or absence of malignancy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subject is medically cleared for surgery.
  • Subject is scheduled to undergo salpingo-oophorectomy or salpingectomy for a pelvic mass suspicious for malignancy
  • Subject must be 18 years of age.
  • Subject must be able to provide informed consent.

Exclusion Criteria:

  • Contraindication to hysteroscopy.
  • Acute pelvic inflammatory disease.
  • Active or recent lower pelvic infection.
  • Pregnancy.
  • Delivery or termination of a pregnancy in the past 6 weeks.
  • Known tubal obstruction.
  • Tubal ligation.
  • Invasive carcinoma of the cervix or endometrium.
  • Intolerance of anesthesia.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Tri Dinh, M.D.

Closed for enrollment

Rochester, Minn.

Mayo Clinic principal investigator

Daniel Breitkopf, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions